Knights Of Columbus Asset Advisors LLC Chemo Centryx, Inc. Transaction History

Knights Of Columbus Asset Advisors LLC

$1.48 Billion
Q3 2024

Shares

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 12, 2021	SELL	$9.59 - $50.88 $259,831 - $1.38 Million	-27,094 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$49.53 - $68.4 $16,840 - $23,256	-340 Reduced 1.24%	27,094 $1.39 Million
Q4 2020 Feb 16, 2021	BUY	$47.25 - $65.16 $1.3 Million - $1.79 Million	27,434 New	27,434 $1.7 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Knights Of Columbus Asset Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knights Of Columbus Asset Advisors LLC with notifications on news.